Massively parallel assessment of human variants with base editor screens
Ruth E. Hanna, Mudra Hegde, Christian R. Fagre, Peter C. DeWeirdt, Annabel K. Sangree, Zsofia M Szegletes, Audrey L Griffith, Marissa N. Feeley, Kendall R Sanson, Yossef Baidi, Luke W. Koblan, David R. Liu, James T. Neal, John G. Doench
This paper uses CRISPR-Cas9 base editors in pooled screens to assess the functional impact of human variants, identifying loss-of-function mutations and drug sensitivity/resistance mutations.
Cell · Feb 1, 2021Peer-reviewedGenetics